Oral manifestations associated with inherited hyperhomocysteinemia: A first case description

Published:September 18, 2021DOI:
      Hyperhomocysteinemia is a rare disease caused by nutritional deficiencies or genetic impairment of cysteine metabolism. To date, no oral manifestations of hyperhomocysteinemia have been described in humans. Therefore, to our knowledge, the present case report is the first description of a hyperhomocysteinemic patient showing oral tissue alterations leading to both early tooth loss and failed implant osseointegration. The patient presented with a methylenetetrahydrofolate reductase gene mutation (677T polymorphism) leading to mild hyperhomocysteinemia. The radiologic analysis showed hyperdense lesions scattered in the maxillae. The histologic observations indicated alterations in both collagen and elastic networks in the gingiva and dermis. Interestingly, the presence of ectopic mineralized inclusions was noted in both periodontal ligament and gingiva. Strong osteoclastic activity was associated with abnormal calcification of trabecular spaces. Uneven oral tissue remodeling due to high tissue levels of homocysteine could explain the pathologic manifestations observed in this case.
      To read this article in full you will need to make a payment


        • Škovierová H
        • Vidomanová E
        • Mahmood S
        • et al.
        The molecular and cellular effect of homocysteine metabolism imbalance on human health.
        Int J Mol Sci. 2016; 17: 1733
        • Levin BL
        • Varga E.
        MTHFR: addressing genetic counseling dilemmas using evidence-based literature.
        J Genet Couns. 2016; 25: 901-911
        • Zappacosta B
        • Mastroiacovo P
        • Persichilli S
        • et al.
        Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia.
        Nutrients. 2013; 5: 1531-1543
        • Leclerc D
        • Sibani S
        • Rozen R.
        Molecular biology of methylenetetrahydrofolate reductase (MTHFR) and overview of mutations/polymorphisms.
        Madame Curie Bioscience Database. Landes Bioscience, Austin, TX2005: 41-54 ([Internet])
        • Ji C
        • Kaplowitz N.
        Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury.
        World J Gastroenterol. 2004; 10: 1699-1708
        • Fratoni V
        • Brandi ML.
        B vitamins, homocysteine and bone health.
        Nutrients. 2015; 7: 2176-2192
        • Joseph R
        • Nath SG
        • Joseraj MG.
        Elevated plasma homocysteine levels in chronic periodontitis: a hospital-based case-control study.
        J Periodontol. 2011; 82: 439-444
        • Stanisic D
        • George AK
        • Smolenkova I
        • et al.
        Hyperhomocysteinemia: an instigating factor for periodontal disease.
        Can J Physiol Pharmacol. 2021; 99: 115-123
        • Wagner EM.
        Monitoring gene expression: quantitative real-time RT-PCR.
        Methods Mol Biol. 2013; 1027: 19-45
        • Liew SC
        • Gupta ED.
        Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.
        Eur J Med Genet. 2015; 58: 1-10
        • Lai WKC
        • Kan MY.
        Homocysteine-induced endothelial dysfunction.
        Ann Nutr Metab. 2015; 67: 1-12
        • Lattouf R
        • Younes R
        • Lutomski D
        • et al.
        Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues.
        J Histochem Cytochem. 2014; 62: 751-758
        • Godeau G.
        Selective staining technique for identification of human skin elastic fibers.
        Pathol Biol (Paris). 1984; 32: 215-216
        • Minkin C.
        Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.
        Calcif Tissue Int. 1982; 34: 285-290
        • Charpiot P
        • Bescond A
        • Augier T
        • et al.
        Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide.
        Matrix Biol. 1998; 17: 559-574
        • Ke XD
        • Foucault-Bertaud A
        • Genovesio C
        • et al.
        Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependent mechanism.
        Mol Cell Biochem. 2010; 335: 203-210
        • Herrmann M
        • Peter Schmidt J
        • Umanskaya N
        • et al.
        The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis: a systematic review.
        Clin Chem Lab Med. 2007; 45: 1621-1632
        • Al-Batayneh KM
        • Al Zoubi MS
        • Shehab M
        • et al.
        Association between MTHFR 677C>T polymorphism and vitamin B12 deficiency: a case-control study.
        J Med Biochem. 2018; 37: 141-147
        • Tanaka T
        • Scheet P
        • Giusti B
        • et al.
        Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations.
        Am J Hum Genet. 2009; 84: 477-482
        • Zong G
        • Holtfreter B
        • Scott AE
        • et al.
        Serum vitamin B12 is inversely associated with periodontal progression and risk of tooth loss: a prospective cohort study.
        J Clin Periodontol. 2016; 43: 2-9
        • Ayanoglou CM.
        Evidence that cyclosporin A administration induces the formation of new cementum-like islets inside the gingival connective tissue.
        J Periodontal Res. 1998; 33: 166-171
        • Tinelli C
        • Di Pino A
        • Ficulle E
        • et al.
        Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies.
        Front Nutr. 2019; 6: 49
        • Koh JM
        • Lee YS
        • Kim YS
        • et al.
        Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation.
        J Bone Miner Res. 2006; 21: 1003-1011
        • Herrmann M
        • Umanskaya N
        • Wildemann B
        • et al.
        Stimulation of osteoblast activity by homocysteine.
        J Cell Mol Med. 2008; 12: 1205-1210
        • Bescond A
        • Augier T
        • Chareyre C
        • et al.
        Influence of homocysteine on matrix metalloproteinase-2: activation and activity.
        Biochem Biophys Res Commun. 1999; 263: 498-503
        • Hubmacher D
        • Tiedemann K
        • Bartels R
        • et al.
        Modification of the structure and function of fibrillin-1 by homocysteine suggests a potential pathogenetic mechanism in homocystinuria.
        J Biol Chem. 2005; 280: 34946-34955
        • Booms P
        • Ney A
        • Barthel F
        • et al.
        A fibrillin-1-fragment containing the elastin-binding-protein GxxPG consensus sequence upregulates matrix metalloproteinase-1: biochemical and computational analysis.
        J Mol Cell Cardiol. 2006; 40: 234-246
        • Nistala H
        • Lee-Arteaga S
        • Smaldone S
        • et al.
        Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation.
        J Cell Biol. 2010; 190: 1107-1121
        • Chaudhry SS
        • Cain SA
        • Morgan A
        • et al.
        Fibrillin-1 regulates the bioavailability of TGFβ1.
        J Cell Biol. 2007; 176: 355-367
        • Sengle G
        • Charbonneau NL
        • Ono RN
        • et al.
        Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
        J Biol Chem. 2008; 283: 13874-13888
        • De Coster PJA
        • Martens LCM
        • De Paepe A.
        Oral manifestations of patients with Marfan syndrome: a case-control study.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93: 564-572
        • Younes R
        • Ghorra C
        • Khalife S
        • et al.
        Pertinent cell population to characterize periodontal disease.
        Tissue Cell. 2009; 41: 141-150